Periprosthetic Infection in Primary and Secondary Augmentation Mammoplasty Using Round Silicone Gel Breast Implants: Comparative Analysis of 2521 Primary and 386 Secondary Mammoplasties in a Single Surgeon Practice
- 29 September 2020
- journal article
- research article
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 45 (1) , 1-10
Abstract
Introduction Wounds are generally classified as clean, clean contaminated, contaminated and dirty. Aesthetic surgery, including breast augmentation, is classified as clean or clean contaminated. The presence of bacteria on the skin, in nipple secretions, in superficial and deep parenchymal samples and also the presence of bacteria in capsules and on implants justifies the use of antibiotics. However, there is a paucity of information about whether added bacterial flora on the capsule of the implant pockets, and the handling of these capsules as capsulotomy or capsulectomy makes secondary augmentation mammoplasty more prone to wound healing issues or periprosthetic infection. The current study is the analysis carried out between primary and secondary augmentation mammoplasties to look at the incidence of periprosthetic infection between the two groups. Material and Methods A retrospective data analysis for periprosthetic infection and wound healing issues following primary and secondary augmentation mammoplasties performed between April 1999 and April 2019 was carried out. Results A total of 2521 (5042 breasts) primary and 386 (772 breasts) secondary augmentation mammoplasty data were available for analysis. Periprosthetic infection was seen in 0.7% and 0.5% of the primary and secondary augmentations, respectively, with no significant difference. Wound healing issues were significantly higher in primary augmentation mammoplasty. Conclusion There was a marginally higher incidence of periprosthetic infection in primary augmentation mammoplasty as compared to secondary augmentation mammoplasty; however, the difference was not significant. On the contrary, the wound healing and superficial skin issues were higher in primary as compared to secondary augmentation mammoplasty, and the difference was statistically significant. Level of Evidence IV This journal requires that authors assign a level of evidence to each article. For a full description of these evidence-based medicine ratings, please refer to the Table of Contents or the online instructions to Authors www.springer.com/00266.Keywords
This publication has 18 references indexed in Scilit:
- Style 410 Highly Cohesive Silicone Breast Implant Core Study Results at 3 YearsPlastic and Reconstructive Surgery, 2007
- Achieving a Zero Percent Reoperation Rate at 3 Years in a 50-Consecutive-Case Augmentation Mammaplasty Premarket Approval StudyPlastic and Reconstructive Surgery, 2006
- Prophylactic antibiotics in aesthetic surgeryAesthetic Surgery Journal, 2006
- Effect of Povidone Iodine on Silicone Gel Breast Implants In Vitro: Implications for Clinical PracticePlastic and Reconstructive Surgery, 2004
- The Role of Prophylactic Antibiotics in Plastic Surgery: Whom Are We Treating?Plastic and Reconstructive Surgery, 2003
- Prophylactic antibiotics in plastic surgery: Trends of use over 25 years of an evolving specialtyAesthetic Surgery Journal, 2003
- Detection of Subclinical Infection in Significant Breast Implant CapsulesPlastic and Reconstructive Surgery, 2003
- Surgical infections: Prevention and treatment—1965 to 1995The American Journal of Surgery, 1996
- The Fate of Breast Implants with Infections Around ThemPlastic and Reconstructive Surgery, 1979
- PARTIALLY SUBMUSCULAR BREAST AUGMENTATIONPlastic and Reconstructive Surgery, 1977